tirzepatide clinical trials on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide: A Systematic Update

tirzepatide clinical trials

tirzepatide clinical trials on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide: A Systematic Update

Name: tirzepatide clinical trials on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide: A Systematic Update
Brand: wefit.es
SKU: 84934890124
Price: 28.73 USD
Availability: InStock
Rating: 4.6867 (23 reviews)

SKU: 84934890124

4.7

USD28.73 USD50.73

Pay in 4 interest-free payments of $7.18 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

1 This new indication adds to the prescribing label for Wegovy , a prescription-only medicine previously approved for adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off when used along with a reduced calorie diet and increased physical activity